Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia
ORIGIN Trial Investigators
Clinical Departments
Hamilton Health Sciences
Université Laval
Estudios Clínicos Latinoamérica
Associazione Nazionale Medici Cardiologi Ospedalieri
University of Washington
India Diabetes Research Foundation
Oregon Health and Science University
Karolinska Institutet
Research output
:
Contribution to journal
›
Article
›
peer-review
809
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cardiovascular Outcomes
100%
3 Fatty Acids
100%
Dysglycemia
100%
N-3 Fatty Acids
100%
Placebo
57%
Confidence Interval
57%
Hazard Ratio
57%
Cardiovascular Events
57%
High Risk
28%
Adverse Effects
14%
2-factorial Design
14%
Lipids
14%
Triglyceride Level
14%
Diabetes
14%
Type 2 Diabetes Mellitus (T2DM)
14%
Heart Failure
14%
Impaired Glucose Tolerance
14%
Arrhythmia
14%
Impaired Fasting Glucose
14%
Major Vascular Injury
14%
Insulin Glargine
14%
Ethyl Esters
14%
Recent Myocardial Infarction
14%
Sanofi
14%
Daily Supplementation
14%
Pharmacology, Toxicology and Pharmaceutical Science
Omega-3 Fatty Acid
100%
Fatty Acid
100%
Dysglycemia
100%
Placebo
57%
Heart Infarction
14%
Triacylglycerol
14%
Congestive Heart Failure
14%
Heart Arrhythmia
14%
Insulin Glargine
14%
Impaired Glucose Tolerance
14%
Non Insulin Dependent Diabetes Mellitus
14%